FDA Modernization Act 2.0 Compliant Β· DART Framework

InSilico
Models

Precision digital animal models for preclinical research and drug discovery. Replace live animal testing with AI-powered, genetically-engineered in silico models β€” enhanced by machine learning and your own experimental data.

14
Species
50+
Strains
29
Drug Compounds
40+
ML Algorithms
8
Disease Areas

Platform Capabilities

Everything you need for AI-powered preclinical research, from genetic engineering to ML-enhanced drug discovery.

CRISPR Genetic Engineering

Knockout, knockin, and point mutations across 12+ disease-relevant genes per species. Predict phenotypic consequences instantly.

Organ-on-Chip Platform

6-organ toxicity profiling (liver, heart, kidney, brain, lung, gut) with real-time biomarker monitoring and dose-response curves.

ML/DL Model Enhancement

40+ algorithms in an interactive Periodic Table. Select any model to enhance DART predictions with your own experimental data.

Data Upload & Training

Upload CSV/Excel experimental data, map columns, select an ML algorithm, and train a custom model in minutes.

Disease Modeling

8 disease areas per species with 28-day biomarker timelines, translational scoring, and FDA Modernization Act 2.0 compliance.

Translational Scoring

AI-powered human predictability scores with ICβ‚…β‚€/ECβ‚…β‚€/LDβ‚…β‚€ pharmacokinetics and therapeutic index calculations.

3Rs Framework

Replace Β· Reduce Β· Refine

InSilico Models is built on the 3Rs ethical framework for animal research. Our DART platform enables complete replacement of animal models with validated digital equivalents, reduction of animal numbers through predictive modeling, and refinement of experimental protocols using AI-guided optimization.

FDA Modernization Act 2.0
EU Directive 2010/63/EU
NC3Rs Guidelines
ICH S7A/S7B Compliant

Start Your Research Today

Sign in to save DART sessions, track experiments, and upload your own data for model training.